Analyst Ratings for Obalon Therapeutics (OBLN)

OBLN Rating Summary

  |   Expand Research on OBLN
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5.7 / 10   Percentile Rank: 61%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/18/2021 Alliance Global Partners N/A New Coverage Buy
(N/A)		 6.15
(N/A)		 4.14
(3.05)		 -26.33% Details
4/8/2019 Canaccord
» Updated 5/22/2019		 Kyle Rose Downgrade Hold
(Buy)		 1.00
(1.50)		 0.56
(3.05)		 444.64% Details